Structure and mechanism of monoamine oxidase - PubMed (original) (raw)
Review
. 2004 Aug;11(15):1983-93.
doi: 10.2174/0929867043364784.
Affiliations
- PMID: 15279562
- DOI: 10.2174/0929867043364784
Review
Structure and mechanism of monoamine oxidase
D E Edmondson et al. Curr Med Chem. 2004 Aug.
Abstract
Monoamine oxidases A and B (MAO A and MAO B) are mitochondrial outer membrane-bound flavoproteins that catalyze the oxidative deamination of neurotransmitters and biogenic amines. A number of mechanism-based inhibitors (MAOI's) have been developed for clinical use as antidepressants and as neuroprotective drugs. To facilitate the development of more effective and specific inhibitors, a detailed understanding of the structures and catalytic mechanisms of these enzymes is required. The recent development of high level expression systems for producing recombinant human liver MAO A and MAO B in Pichia pastoris has facilitated the determination of the three dimensional crystal structures of MAO B (up to 1.7 angstroms resolution) in complex with different reversible (isatin, 1,4-diphenyl-2-butene) and irreversible inhibitors (pargyline, N-(2-aminoethyl)-p-chlorobenzamide, and trans-2-phenylcyclopropylamine). The binding of substrates or inhibitors to MAO B involves an initial negotiation of a protein loop occurring near the surface of the membrane and two hydrophobic cavities; an "entrance" cavity and an "active site" cavity. These two cavities can either be separate or in a fused state depending on the conformation of the Ile199 side chain, which appears to function as a gate. The amine function of the bound substrate approaches the re face of the bent and "puckered" covalent FAD through an "aromatic cage" formed by two tyrosine residues that are perpendicular to the plane of the flavin ring. No amino acid residues that could function as acids or bases are found near the catalytic site. The existing structural data on MAO B support previous QSAR results and are also supportive of a proposed polar nucleophilic mechanism for MAO A and B catalysis rather than the alternatively proposed single electron transfer mechanism.
Copyright 2004 Bentham Science Publishers Ltd.
Similar articles
- Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures.
Binda C, Li M, Hubalek F, Restelli N, Edmondson DE, Mattevi A. Binda C, et al. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9750-5. doi: 10.1073/pnas.1633804100. Epub 2003 Aug 11. Proc Natl Acad Sci U S A. 2003. PMID: 12913124 Free PMC article. - Functional role of the "aromatic cage" in human monoamine oxidase B: structures and catalytic properties of Tyr435 mutant proteins.
Li M, Binda C, Mattevi A, Edmondson DE. Li M, et al. Biochemistry. 2006 Apr 18;45(15):4775-84. doi: 10.1021/bi051847g. Biochemistry. 2006. PMID: 16605246 - Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design.
Binda C, Hubálek F, Li M, Castagnoli N, Edmondson DE, Mattevi A. Binda C, et al. Neurology. 2006 Oct 10;67(7 Suppl 2):S5-7. doi: 10.1212/wnl.67.7_suppl_2.s5. Neurology. 2006. PMID: 17030739 - Structural properties of human monoamine oxidases A and B.
Binda C, Mattevi A, Edmondson DE. Binda C, et al. Int Rev Neurobiol. 2011;100:1-11. doi: 10.1016/B978-0-12-386467-3.00001-7. Int Rev Neurobiol. 2011. PMID: 21971000 Review. - The FAD binding sites of human monoamine oxidases A and B.
Edmondson DE, Binda C, Mattevi A. Edmondson DE, et al. Neurotoxicology. 2004 Jan;25(1-2):63-72. doi: 10.1016/S0161-813X(03)00114-1. Neurotoxicology. 2004. PMID: 14697881 Review.
Cited by
- In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions.
Flanagan S, Bartizal K, Minassian SL, Fang E, Prokocimer P. Flanagan S, et al. Antimicrob Agents Chemother. 2013 Jul;57(7):3060-6. doi: 10.1128/AAC.00431-13. Epub 2013 Apr 22. Antimicrob Agents Chemother. 2013. PMID: 23612197 Free PMC article. Clinical Trial. - Computational modeling of the direct hydride transfer mechanism for the MAO catalyzed oxidation of phenethylamine and benzylamine: ONIOM (QM/QM) calculations.
Akyüz MA, Erdem SS. Akyüz MA, et al. J Neural Transm (Vienna). 2013 Jun;120(6):937-45. doi: 10.1007/s00702-013-1027-8. Epub 2013 Apr 26. J Neural Transm (Vienna). 2013. PMID: 23619993 - Platelet monoamine oxidase-A activity and aging: effect of carnosine.
Banerjee S, Poddar MK. Banerjee S, et al. J Physiol Sci. 2013 Jul;63(4):279-85. doi: 10.1007/s12576-013-0264-9. Epub 2013 May 9. J Physiol Sci. 2013. PMID: 23657886 Free PMC article. - Potential Roles of microRNAs in the Regulation of Monoamine Oxidase A in the Brain.
Higuchi Y, Soga T, Parhar IS. Higuchi Y, et al. Front Mol Neurosci. 2018 Sep 14;11:339. doi: 10.3389/fnmol.2018.00339. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30271325 Free PMC article. Review. - Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapy.
Pachón-Angona I, Refouvelet B, Andrýs R, Martin H, Luzet V, Iriepa I, Moraleda I, Diez-Iriepa D, Oset-Gasque MJ, Marco-Contelles J, Musilek K, Ismaili L. Pachón-Angona I, et al. J Enzyme Inhib Med Chem. 2019 Dec;34(1):479-489. doi: 10.1080/14756366.2018.1545766. J Enzyme Inhib Med Chem. 2019. PMID: 30712420 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources